October 31, 2024
Dr. Sylvia Villeneuve has been nominated as one of the winners of the Weston Foundation‘s “Brain Health: Sleep 2023” program. This program aims to explore sleep-related approaches to reducing the risk of age-related neurodegenerative diseases.
Dr. Villeneuve’s project, entitled Improving Sleep to Prevent Alzheimer’s Disease, investigates how poor sleep quality may increase the risk of developing Alzheimer’s disease. Her approach combines an observational study of the effects of sleep on the brain with a clinical trial testing the efficacy of the drug Lemborexant in preventing disease-related pathologies. This project could significantly improve our understanding of the link between sleep and the prevention of Alzheimer’s disease.
This funding will allow us to better understand the associations between sleep and Alzheimer’s pathological and clinical progession. With no cure we need to find ways to slow the disease progression, ideally when people are still asymptomatic, which is what my research is currently targeting.
– Sylvia Villeneuve
For this project, Dr. Sylvia Villeneuve received over $1.5 M from the Weston Foundation.
Congratulations Dr. Villeneuve!